
|Articles|March 31, 2008
FDA studying if gel for diabetic ulcers causes cancer
Regranex is being studied by the FDA on whether it is linked to higher rates of cancer.
Advertisement
Is Regranex (becaplermin, Johnson & Johnson) Gel, which helps heal foot and leg diabetic ulcers, associated with higher rates of cancer death? That?s what the Food & Drug Administration is now studying. In an early
To see more Daily News articles,
To go to the Drug Topics homepage,
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Pharmacists Provide Tailored Pneumococcal Vaccines to Patients With Down Syndrome
2
Finerenone Shows Benefits for Chronic Kidney Disease for Patients With Type 1 Diabetes
3
FDA Approves Lumateperone as Adjunct Therapy for Major Depressive Disorder
4
Dementia Increases Risk of COVID-19 Infection, Hospitalization for Older Patients
5




















































































































































